Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1→3)-β-d-glucan in clinical specimens

References

1. Ahmad S., Khan Z., Mustafa A. S., Khan Z. U. 2002; Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection and biochemical methods for species identification. J Clin Microbiol 40:2483–2489 [CrossRef]
   [Google Scholar]
2. Ahmad S., Al-Mahmeed M., Khan Z. U. 2005; Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol 54:639–646 [CrossRef]
   [Google Scholar]
3. Aliff T. B., Maslak P. G., Jurcic J. G., Heaney M. L., Cathcart K. N., Sepkowitz K. A., Weiss M. A. 2003; Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer 97:1025–1032 [CrossRef]
   [Google Scholar]
4. Arikan S., Lozano-Chiu M., Paetznick V., Rex J. H. 2002; In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother 46:245–247 [CrossRef]
   [Google Scholar]
5. Ascioglu S., Rex J. H., de Pauw B., Bennett J. E., Bille J., Crokaert F., Denning D. W., Donnelly J. P., Edwards J. E. & other authors, on behalf of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases; 2002; Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14 [CrossRef]
   [Google Scholar]
6. Coley S. C., Jager H. R., Szydlo R. M., Goldman J. M. 1999; CT and MRI manifestations of central nervous system infection following allogeneic bone marrow transplantation. Clin Radiol 54:390–397 [CrossRef]
   [Google Scholar]
7. Hope W. W., Walsh T. J., Denning D. W. 2005; Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5:609–622 [CrossRef]
   [Google Scholar]
8. Kami M., Ogawa S., Kanda Y., Tanaka Y., Machida U., Matsumura T., Sakamaki H., Hirai H. 1999; Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay. Br J Haematol 106:536–537 [CrossRef]
   [Google Scholar]
9. Kontoyiannis D. P., Hachem R., Lewis R. E., Rivero G. A., Torres H. A., Thornby J., Champlin R., Kantarjian H., Bodey G. P., Raad I. I. 2003; Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer 98:292–299 [CrossRef]
   [Google Scholar]
10. Liu K., Howell D. N., Perfect J. R., Schell W. A. 1998; Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces and Acremonium species by histopathology. Am J Clin Pathol 109:45–54
    [Google Scholar]
11. Maertens J., Raad I., Petrikkos G., Boogaerts M., Selleslag D., Petersen F. B., Sable C. A., Kartsonis N. A., Ngai A. & other authors for the Caspofungin Salvage Aspergillosis Study Group; 2004; Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39:1563–1571 [CrossRef]
    [Google Scholar]
12. Marr K. A., Boeckh M., Carter R. A., Kim H. W., Corey L. 2004; Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 39:797–802 [CrossRef]
    [Google Scholar]
13. Oakley K. L., Moore C. B., Denning D. W. 1998; In vitro activity of the echinocandin antifungal agent LY303, 366 in comparison with itraconazole and amphotericin B against Aspergillus spp. Antimicrob Agents Chemother 42:2726–2730
    [Google Scholar]
14. Ostrosky-Zeichner L., Alexander B. D., Kett D. H., Vazquez J., Pappas P. G., Saeki F., Ketchum P. A., Wingard J., Schiff R. other authors 2005; Multicenter clinical evaluation of the (1→3) β -d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 41:654–659 [CrossRef]
    [Google Scholar]
15. Pickering J. W., Sant H. W., Bowles C. A., Roberts W. L., Woods G. L. 2005; Evaluation of a (1→3)- β -d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43:5957–5962 [CrossRef]
    [Google Scholar]
16. Randhawa H. S., Kowshik T. K., Sinha P., Sandhu R. S., Chowdhary A. 2005; Peptone glucose fluconazole agar, a selective medium for rapid and enhanced isolation of Aspergillus fumigatus from aqueous suspensions and sputum seeded with Candida albicans . Curr Sci 88:449–454
    [Google Scholar]
17. Schwartz S., Thiel E. 2004; Update on the treatment of cerebral aspergillosis. Ann Hematol 83 (Suppl. 1):S42–S44
    [Google Scholar]
18. Singh N., Paterson D. L. 2005; Aspergillus infections in transplant recipients. Clin Microbiol Rev 18:44–69 [CrossRef]
    [Google Scholar]
19. Sutton D. A., Sanche S. E., Revankar S. G., Fothergill A. W., Rinaldi M. G. 1999; In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus , with a head-to-head comparison to voriconazole. J Clin Microbiol 37:2343–2345
    [Google Scholar]
20. Verweij P. E., Brinkman K., Kremer H. P., Kullberg B. J., Meis J. F. 1999; Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol 37:1186–1189
    [Google Scholar]